Literature DB >> 17903513

Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest.

Bahaaldin Alsoufi1, Osman O Al-Radi, Rakan I Nazer, Colleen Gruenwald, Celeste Foreman, William G Williams, John G Coles, Christopher A Caldarone, Desmond G Bohn, Glen S Van Arsdell.   

Abstract

OBJECTIVES: We report our experience with extracorporeal cardiopulmonary resuscitation with extracorporeal membrane oxygenation in children having cardiac arrest refractory to conventional cardiopulmonary resuscitation and explore predictors for favorable outcome (survival with grossly intact neurologic status).
METHODS: We reviewed all patients who required extracorporeal cardiopulmonary resuscitation from 2000 to 2005. Multivariable regression analysis determined factors associated with favorable outcome and time-related survival.
RESULTS: Eighty children, median age 150 days (range: 1 day-17.6 years), required venoarterial extracorporeal cardiopulmonary resuscitation. There were several categories of disease among the patients: postcardiotomy (n = 39), unoperated congenital heart disease (n = 17), cardiomyopathy (n = 12), respiratory failure (n = 9), or myocarditis (n = 3). Cannulation sites were neck (n = 45) or chest (n = 36). Median duration of extracorporeal membrane oxygenation was 4 days (range: 1-22). Extracorporeal membrane oxygenation was successfully discontinued in 42 (54%) patients: wean (n = 35), heart transplantation (n = 7). Survival till hospital discharge was 27 (34%) patients. Most common cause of death was ischemic brain injury (n = 17). Twenty-four (30%) patients had a favorable outcome. Median duration of cardiopulmonary resuscitation for patients with favorable versus unfavorable outcome was 46 minutes (range: 14-95; interquartile range: 29-55) versus 41 minutes (range: 19-110; interquartile range: 30-55), P = .916. According to the logistic regression model, none of the following factors was a significant predictor of favorable outcome: age, weight, sex, etiology (cardiac vs noncardiac), duration of cardiopulmonary resuscitation, cannulation site, timing, or location of extracorporeal membrane oxygenation institution.
CONCLUSIONS: Acceptable survival and neurologic outcomes (30%) can be achieved with extracorporeal cardiopulmonary resuscitation in children after prolonged cardiac arrest (up to 95 minutes) refractory to conventional resuscitation measures. Heart transplantation is often needed for successful extracorporeal cardiopulmonary resuscitation exit strategy. Lack of predictors of poor outcome support aggressive attempts to initiate extracorporeal cardiopulmonary resuscitation in all patients, followed by subsequent assessment of organ salvage.

Entities:  

Mesh:

Year:  2007        PMID: 17903513     DOI: 10.1016/j.jtcvs.2007.05.054

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  39 in total

Review 1.  Pediatric neurocritical care.

Authors:  Sarah Murphy
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

3.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

4.  Feasibility of initiating extracorporeal life support during mechanical chest compression CPR: a porcine pilot study.

Authors:  James J Menegazzi; David D Salcido; Greggory J Housler; Eric S Logue
Journal:  Resuscitation       Date:  2011-08-09       Impact factor: 5.262

5.  Extracorporeal Life Support as a Rescue Measure for Managing Life-Threatening Arrythmia and Brugada Syndrome.

Authors:  Asaad G Beshish; Allison Weinberg; Waseem Ostwani; Gabe E Owens
Journal:  J Extra Corpor Technol       Date:  2017-12

6.  Outcome predictors of pediatric extracorporeal cardiopulmonary resuscitation.

Authors:  Robert B Kelly; Rick E Harrison
Journal:  Pediatr Cardiol       Date:  2010-02-10       Impact factor: 1.655

7.  Female sex is not associated with improved rates of ROSC or short term survival following prolonged porcine ventricular fibrillation.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2012-03-20       Impact factor: 5.262

8.  Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation.

Authors:  Melania M Bembea; William Savage; John J Strouse; Jamie McElrath Schwartz; Ernest Graham; Carol B Thompson; Allen Everett
Journal:  Pediatr Crit Care Med       Date:  2011-09       Impact factor: 3.624

9.  The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.

Authors:  Enno D Wildschut; Annewil van Saet; Pavla Pokorna; Maurice J Ahsman; John N Van den Anker; Dick Tibboel
Journal:  Pediatr Clin North Am       Date:  2012-08-29       Impact factor: 3.278

10.  Early clinical outcomes of new pediatric extracorporeal life support system (Endumo (2000) in neonates and infants.

Authors:  Takaya Hoashi; Koji Kagisaki; Kizuku Yamashita; Eisuke Tatsumi; Takayuki Nishigaki; Kotaro Yoshida; Teruyuki Hayashi; Hajime Ichikawa
Journal:  J Artif Organs       Date:  2013-05-30       Impact factor: 1.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.